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patients undergoing the procedure.2 Nevertheless, the
quest for less invasive therapeutic alternatives spawned
interest in the procedure of percutaneous carotid angio-
plasty and stenting. Although percutaneous carotid inter-
ventions have not been subjected to the rigors of a
controlled clinical trial, a number of registries have been
organized and plans for large, multicenter, randomized
comparisons are underway. Given the uncertainties associ-
ated with carotid angioplasty and stenting, the initial
assessment of the procedure may be best undertaken in a
subgroup of patients at high risk for complications with
standard carotid surgery. In an effort to characterize such
a subgroup, we reviewed the results of carotid endarterec-
tomy in patients with and without significant medical
comorbidity.
MATERIALS AND METHODS
During a 10-year period ending on December 31,
1998, 3061 carotid endarterectomies were performed at a
single institution and entered prospectively into a com-
puterized registry. The presenting symptoms were those of
transient ischemic attacks (TIAs) in 742 patients (24.2%)
and stroke in 341 patients (11.1%), whereas 1978 patients
(64.6%) had asymptomatic, critically stenotic carotid
lesions (Table I). Preoperative baseline comorbid condi-
tions were recorded at the time of admission, as were the
in-hospital complications of stroke, myocardial infarction,
and death. Patients were subdivided into high-risk and
low-risk subgroups, defining the high-risk patients as
Surgical treatment of carotid disease was first reported
by Eastcott, Pickering, and Rob in 1954,1 when a patient
with crescendo transient ischemic events underwent resec-
tion of the proximal internal carotid artery and reimplan-
tation of the internal carotid artery stump onto the
common carotid artery. This procedure resulted in imme-
diate resolution of the patient’s symptoms and heralded
the age of carotid surgery that culminated in the perfor-
mance of greater than 100,000 carotid endarterectomies
in the United States annually at the turn of the millen-
nium.1a
With only minor technical modifications, carotid
endarterectomy has remained the standard with which all
other newer therapies must be compared. In contempo-
rary series the rate of perioperative morbidity and mortal-
ity has reached extraordinarily low levels. A collection of
large series published after 1984 documented a 2.8% inci-
dence of perioperative stroke, with death in only 1.1% of
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Purpose: Given the uncertainties associated with carotid angioplasty and stenting, the initial assessment of the proce-
dure may be best undertaken in a subgroup of patients at increased risk for complications with standard carotid surgery.
In an effort to characterize such a subgroup, we reviewed the results of carotid endarterectomy in patients with and
without significant medical comorbidity.
Methods: During a 10-year period 3061 carotid endarterectomies were performed at a single institution and entered
prospectively into a registry. A high-risk patient subgroup was identified, defined by the presence of severe coronary
artery disease, chronic obstructive lung disease, or renal insufficiency. The outcome of carotid endarterectomy was
assessed with respect to perioperative stroke, myocardial infarction, or death, as well as the combined end point of one
or more of the end points.
Results: The rate of the composite end point stroke/myocardial infarction/death was 3.8% in the total group of 3061
patients who underwent endarterectomy. As individual end points, the rate of stroke was 2.1%, myocardial infarction
1.2%, and death 1.1%. Among the high-risk subset, the composite end point stroke/myocardial infarction/death
occurred in 7.4%. This rate was significantly greater than the corresponding rate of 2.9% in the low-risk subset (P <
.0005). Similarly, the rate of stroke (3.5% vs 1.7%, P = .008) or death (4.4% vs 0.3%, P < .001) as solitary events was
significantly greater in high-risk patients.
Conclusions: Although carotid endarterectomy is an extremely safe procedure in most patients, results are not as favor-
able in a high-risk subset with severe coronary, pulmonary, or renal disease. The initial clinical evaluation of carotid
stenting might best be undertaken in such a high-risk population, one that comprises patients for whom standard ther-
apy is associated with a high rate of complications. (J Vasc Surg 2001;33:728-32.)
those with one or more of the following: coronary artery
disease requiring angioplasty or bypass grafting within the
6 months preceding carotid repair, history of congestive
heart failure (CHF), severe chronic obstructive pulmonary
disease (COPD), or renal insufficiency with creatinine
level greater than 3.0 mg/dL. Overall, 594 patients
(19.4%) met the criteria for the high-risk subset, and 2467
patients (80.6%) were considered low-risk (Fig 1). The
high-risk subset was further divided into those patients
who underwent open cardiac surgical procedures and
carotid endarterectomy at the same sitting (399 patients,
67.2%) and those who did not (195 patients, 32.8%).
Further, each subset was subcategorized by presenting
symptom complex, asymptomatic, TIA, or stroke.
The rate of in-hospital stroke, myocardial infarction,
and death, as well as the composite end point of one or
more of these three events, were calculated for the high-
and low-risk subsets. It should be noted that, in this
prospective registry analysis, it was possible that minor
postprocedure cardiac and neurologic events were not
recorded; cardiology and neurology consultations were
not mandated. Event rates were compared between
groups with a χ2 analysis, assuming significance when the
2-tailed P value was less than .05.
RESULTS
The rate of the composite end point stroke/myocar-
dial infarction/death was 3.8% (115 patients) in the total
group of 3061 patients who underwent endarterectomy
(Table I). As individual end points, the rate of stroke was
2.1%, myocardial infarction 1.2%, and death 1.1%. Patients
with asymptomatic carotid lesions had a lower rate of peri-
operative morbid events compared with patients with
stroke as the presenting symptom (3.3% vs 6.2%, P =
.019). Patients presenting with TIA had a rate of periop-
erative stroke, myocardial infarction, or death that was
intermediate between the two other groups (3.8%, P =
.192 vs asymptomatic patients, P = .115 vs patients with
stroke).
The rate of perioperative stroke/myocardial infarc-
tion/death was greater in those who had concurrent cardiac
surgery and carotid endarterectomy than in those undergo-
ing carotid endarterectomy alone, 8.5% vs 3.0% (P <
.0005). Stroke alone also occurred with greater frequency
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in patients with combined cardiac/carotid procedures, 4.8%
vs 1.7% (P < .0005), as did death, 5.3% vs 0.5% (P < .0001).
By contrast, the frequency of perioperative myocardial
infarction was not statistically dissimilar in patients with
combined procedures (1.8%) versus those in whom a
carotid procedure was performed alone (1.1%, P = .412).
Among patients who met the criteria for high risk, the
composite end point stroke/myocardial infarction/death
occurred in 7.4% during the index hospitalization (Fig 2,
Table II). This rate was significantly greater than the 
corresponding rate of 2.9% in the low-risk subset 
(P < .0005). Similarly, the rate of stroke (3.5% vs 1.7%, 
P = .008) or death (4.4% vs 0.3%, P < .001) as solitary
events was significantly greater in the high-risk subset.
The results were similar when patients undergoing con-
current cardiac and carotid procedures were evaluated
separately (Table III). The rate of each adverse event was
lower in patients undergoing carotid procedures alone
when compared with patients undergoing combined
carotid/cardiac procedures. Within the subgroup of
patients undergoing carotid procedures alone, the risk of
death was significantly greater in the high-risk subgroup
(P < .001). The risk of the composite end point death,
myocardial infarction, or stroke appeared to be greater in
the high-risk patients, but this difference did not attain
statistical significance (P = .078). The rates of myocardial
infarction and stroke as solitary end points did not differ
significantly between the high- and low-risk subgroups.
Among patients undergoing combined procedures, the
composite end point and stroke occurred more frequently
in patients with risk factors (P = .010 and P = .021,
respectively), but there were no significant differences in
the frequency of death or myocardial infarction as solitary
end points.
Among the group undergoing combined cardiac and
coronary procedures, patients with a history of CHF,
severe COPD, or renal insufficiency with serum creatinine
level greater than 3.0 mg/dL, stroke, death, or myocardial
infarction occurred with significantly greater frequency
than in those who did not manifest one of these baseline
comorbidities. The rate of the composite end point rose to
15.5% in this subgroup of patients, compared with 6.7% in
Fig 1. Proportion of patients by risk category.
Fig 2. Rate of perioperative events in low- and high-risk sub-
groups. MI, Myocardial infarction.
patients undergoing combined procedures who did not
manifest one of the comorbidities (P = .020).
DISCUSSION
Carotid endarterectomy is considered to be a remark-
ably safe procedure with well-proven benefits in sympto-
matic and asymptomatic patients with high-grade stenotic
lesions.3,4 Among 326 patients in the North American
Symptomatic Carotid Endarterectomy Trial (NASCET)
who underwent carotid endarterectomy for symptomatic
stenotic lesions of 70% or greater diameter reduction, the
risk of stroke or death was 5.5% within 30 days of opera-
tion.5 There was a 17% absolute risk reduction in the 2-
year risk of ipsilateral stroke when compared with patients
treated medically. Among 1087 patients in the NASCET
trial who underwent endarterectomy for lesions between
50% and 69% diameter reduction, the 30-day ipsilateral
stroke rate was 5.6% within 30 days of operation.6 In this
group with more moderate stenoses, there was a 6.5%
absolute risk reduction (15.7% vs 22.2%, 29% relative risk
reduction) in the 5-year risk of ipsilateral stroke compared
with patients treated medically. The Asymptomatic
Carotid Atherosclerosis Study (ACAS) documented simi-
lar benefits of carotid endarterectomy in patients with
asymptomatic carotid stenoses of greater than 60%.7 The
risk of perioperative morbid events was extremely low in
the ACAS population, with a 30-day ipsilateral stroke rate
of 1.8% (0.6% attributable to angiography and 1.2% to the
operative procedure) and a mortality rate of 0.1%. The risk
of the composite end point (perioperative stroke, death, or
ipsilateral stroke) during a period of 5 years was 5.1% for
surgically treated patients versus 11.0% for those treated
medically. Carotid endarterectomy was associated with a
53% reduction in the risk of the primary end point during
5 years of follow-up.
The publication of the NASCET and ACAS data was
associated with a dramatic increase in the number of
patients undergoing carotid endarterectomy, although a
causal relationship can only be suspected. In Medicare
beneficiaries, the frequency of the procedure decreased
from 61,273 per annum in 1985 to 46,571 in 1989, ris-
ing to 108,275 in 1996 after the appearance of the data
from the randomized trials.1,8 At the same time, the mor-
tality rate in these patients decreased from 3.0% in 1985 to
2.5% in 1989 and to 1.6% in 1996.
The excellent outcomes of the randomized trials can-
not, however, be directly applied to the total population of
patients undergoing carotid endarterectomy. In fact, there
exist data to suggest that the results of the trials cannot be
generalized to patients undergoing endarterectomy at the
hospitals that participated in the studies. Hsia et al8
reported that the 30-day mortality rate in Medicare bene-
ficiaries undergoing carotid endarterectomy in high-
volume urban teaching hospitals of the type that partici-
pated in the clinical trials was only 1.0%, compared with
greater than 2.5% overall. In a study of 113,000 Medicare
patients who underwent carotid endarterectomy during
the conduct of the NASCET and ACAS trials (1992 to
1993), Wennberg et al9 noted that the perioperative mor-
tality rate was 1.4% in hospitals participating in the trials
and 1.7% in hospitals that did not participate in the trials.
The rate of perioperative death rose to 2.5% in low-
volume nontrial hospitals where fewer than seven carotid
endarterectomies were performed yearly. These relatively
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Table I. Rate complications by indication for operation
Indication N % Total Composite % Death % Stroke % MI %
Asymptomatic 1978 64.6 66 3.3 19 1.0 32 1.6 23 1.2
TIA 742 24.2 28 3.8 8 1.1 20 2.7 6 0.8
Stroke 341 11.1 21 6.2 7 2.1 11 3.2 8 2.3
Total 3061 100.0 115 3.8 34 1.1 63 2.1 37 1.2
Composite end point occurred when the patient experienced one or more of the solitary end points: death, stroke, or myocardial infarction (MI).
Table II. Rate of stroke, myocardial infarction, and death in low-risk and high-risk patients undergoing carotid
endarterectomy
Total 
Risk group Indication patients % Total D/S/MI % Death % Stroke % MI %
High risk Asymptomatic 436 73.4 30 6.9 16 3.7 14 3.2 5 1.1
TIA 107 18.0 9 8.4 6 5.6 4 3.7 3 2.8
Stroke 51 8.6 5 9.8 4 7.8 3 5.9 2 3.9
Total 594 19.4 44 7.4 26 4.4 21 3.5 10 1.7
Low risk Asymptomatic 1542 62.5 36 2.3 3 0.2 18 1.2 18 1.2
TIA 635 25.7 19 3.0 2 0.3 16 2.5 3 0.5
Stroke 290 11.8 16 5.5 3 1.0 8 2.8 6 2.1
Total 2467 80.6 71 2.9 8 0.3 42 1.7 27 1.1
D/S/MI, Composite end point of death, stroke, or myocardial infarction.
high complication rates are in direct contrast to the much
lower mortality rates observed in the patients entered into
the trials (0.1% in ACAS and 0.6% in NASCET). These
findings suggest that eligibility criteria were sufficiently
strict that patients in the NASCET and ACAS represented
a small subset of the total population of patients undergo-
ing carotid endarterectomy, comprising a subgroup with
the lowest frequency of baseline comorbid conditions and,
likely, the lowest rate of perioperative adverse events.
These observations also question the widely held belief
that carotid endarterectomy is a trivial procedure with an
almost nonexistent rate of perioperative mortality.
The data from the Cleveland Clinic registry offer an
explanation for the findings of Wennberg et al.9 Patients in
the multicenter trials of carotid endarterectomy were likely
similar to the low-risk group of patients undergoing carotid
repair at the Cleveland Clinic. In fact, the mortality rate of
0.2% in 1542 low-risk asymptomatic patients treated with
carotid endarterectomy is remarkably similar to the ACAS
mortality rate of 0.1%. Similarly, the mortality rate was 0.5%
in 925 symptomatic patients undergoing carotid
endarterectomy at the Cleveland Clinic, almost identical to
the 0.6% mortality rate observed in the NASCET trial.
These observations have implications in the design of
trials aimed at assessing carotid stenting procedures.
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Periprocedural morbidity is likely to be highest during the
relatively early evolution of stent design and stenting treat-
ment paradigms. At a time when the safety and efficacy of
carotid stenting remain unproved, investigations seem
most appropriately undertaken in the population of
patients with less ideal outcomes following the standard
therapy of carotid endarterectomy. The current study
sought to identify comorbid conditions that increase the
risk of endarterectomy; there exist a variety of anatomic
features that are also associated with poorer outcome.
These include such variables as contralateral carotid occlu-
sion,6 recurrent carotid lesions,10 and a history of radia-
tion therapy to the neck.11 In addition, authors such as
Sundt et al12 and, more recently, Rockwell et al13 have
outlined other clinical and anatomic factors that are asso-
ciated with an increased risk for poor outcome after
carotid endarterectomy. These issues may be of equal or
greater importance than medical comorbidities and should
be the topic of subsequent investigations.
Whereas it may be unrealistic to assume that the
results of carotid stenting will attain clinical equipoise with
endarterectomy in all patient subgroups, it seems quite
reasonable to predict that this potentially less invasive pro-
cedure will result in a lower complication rate in medically
compromised, high-risk patients. If equivalence of carotid
Table III. Rate of stroke, myocardial infarction (MI), and death in patients undergoing carotid endarterectomy alone
and in combination with cardiac procedures, subgrouped with respect to the presence or absence of risk factors (coro-
nary artery procedures within 6 months, history of CHF, severe COPD, or creatinine level greater than 3.0 mg/dL)
Cartoid/ Risk Total
cardiac group Indication patients % Total Composite % Death % Stroke % MI %
Cartoid alone With risk factors Asymptomatic 130 66.7 6 4.6 3 2.3 2 1.5 1 0.8
TIA 42 21.5 2 4.8 1 2.4 0 0.0 1 2.4
Stroke 23 11.8 2 8.7 1 4.3 0 0.0 1 4.3
Total 195 6.4 10 5.1 5 2.6 2 1.0 3 1.5
Without risk factors Asymptomatic 1542 62.5 36 2.3 3 0.2 18 1.2 18 1.2
TIA 635 25.7 19 3.0 2 0.3 16 2.5 3 0.5
Stroke 290 11.8 16 5.5 3 1.0 8 2.8 6 2.1
Total 2467 80.6 71 2.9 8 0.3 42 1.7 27 1.1
All Asymptomatic 1672 62.8 42 2.5 6 0.4 20 1.2 19 1.1
TIA 677 25.4 21 3.1 3 0.4 16 2.4 4 0.6
Stroke 313 11.8 18 5.8 4 1.3 8 2.6 7 2.2
Total 2662 87.0 81 3.0 13 0.5 44 1.7 30 1.1
Cartoid with cardiac With risk factors Asymptomatic 66 78.6 9 13.6 4 6.1 5 7.6 2 3.0
TIA 11 13.1 2 18.2 1 9.1 2 18.2 1 9.1
Stroke 7 8.3 2 28.6 2 28.6 1 14.3 0 0.0
Total 84 2.7 13 15.5 7 8.3 8 9.5 3 3.6
Without risk factors Asymptomatic 240 76.2 15 6.3 9 3.8 7 2.9 2 0.8
TIA 54 17.1 5 9.3 4 7.4 2 3.7 1 1.9
Stroke 21 6.7 1 4.8 1 4.8 2 9.5 1 4.8
Total 315 10.3 21 6.7 14 4.4 11 3.5 4 1.3
All Asymptomatic 306 76.7 24 7.8 13 4.2 12 3.9 4 1.3
TIA 65 16.3 7 10.8 5 7.7 4 6.2 2 3.1
Stroke 28 7.0 3 10.7 3 10.7 3 10.7 1 3.6
Total 399 13.0 34 8.5 21 5.3 19 4.8 7 1.8
Total 3061 100.0 115 3.8 34 1.1 63 2.1 37 1.2
Composite end point is defined by the occurrence of perioperative stroke, MI, or death.
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stenting to endarterectomy cannot be demonstrated in
this group of patients with less ideal outcomes after
carotid endarterectomy, it is unlikely that stenting can
compete successfully with endarterectomy in a lower risk
group. These considerations argue for focusing on an eval-
uation of stenting in a select subset of the population with
carotid disease, a subset in which standard therapy is asso-
ciated with a high rate of complications on the basis of sig-
nificant baseline medical comorbidities.
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